Application of the Neurosphere Assay for DNT Hazard Assessment: Challenges and Limitations

Methods in Pharmacology and Toxicology

Volumn , Issue , 2015, Pages 1-29

  Baumann, Jenny ^a   Dach, Katharina ^a   Barenys, Marta ^a   Giersiefer, Susanne ^a   Goniwiecha, Janette ^a   Lein, Pamela J ^a   Fritsche, Ellen ^a  

^a NONE

Author keywords

Brain development; Developmental neurotoxicity; Human; In vitro; Mouse; Neural progenitor cell; Rat; Species differences

Indexed keywords

EID: 85144885421     PISSN: 15572153     EISSN: 19406053     Source Type: Book Series    
DOI: 10.1007/7653_2015_49     Document Type: Chapter

References (112)

1. Albright TD, Jessell TM, Kandel ER, Posner MI (2000) Neural science: a century of progress and the mysteries that remain. Neuron 25 (1):S1–S55
2. Kandel ER, Schwartz, JH, Jessell TM (2000) The development of the nervous system. In: Kandel ER, Schwartz JH, Jessell TM (ed) Principles of neural science. New York, pp 1019–1114
3. Knecht AK, Bronner-Fraser M (2002) Induction of the neural crest: a multigene process. Nat Rev Genet 3(6):453–461
4. Alvarez-Buylla A, García-Verdugo JM, Tramontin AD (2001) A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci 2(4):287–293
5. Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27(1):3–18
6. Ek CJ, Dziegielewska KM, Habgood MD, Saunders NR (2012) Barriers in the developing brain and Neurotoxicology. Neurotoxicology 33(3):586–604
7. Rodier PM (1995) Developing brain as a target of toxicity. Environ Health Perspect 103 (Suppl 6):73–76
8. Collins FS, Gray GM, Bucher JR (2008) Transforming environmental health protection. Science 319(5865):906–907
9. Gassmann K, Baumann J, Giersiefer S, Schuwald J, Schreiber T, Merk H, Fritsche E (2012) Automated neurosphere sorting and plating by the COPAS large particle sorter is a suitable method for high-throughput 3D in vitro applications. Toxicol in Vitro 26 (6):993–1000
10. Culbreth ME, Harrill JA, Freudenrich TM, Mundy WR, Shafer TJ (2012) Comparison of chemical-induced changes in proliferation and apoptosis in human and mouse neuroprogenitor cells. Neurotoxicology 33 (6):1499–1510
11. Harrill JA, Freudenrich TM, Robinette BL, Mundy WR (2011) Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicol Appl Pharmacol 256 (3):268–280
12. Radio NM, Freudenrich TM, Robinette BL, Crofton KM, Mundy WR (2010) Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis. Neurotoxicol Teratol 32(1):25–35
13. Cukierman E, Pankov R, Stevens DR, Yamada KM (2001) Taking cell-matrix adhesions to the third dimension. Science 294 (5547):1708–1712
14. Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130(4):601–610
15. Alépée N, Bahinski T, Daneshian M, De Wever B, Fritsche E, Goldberg A, Hansmann J, Hartung T, Haycock J, Hogberg H (2013) State-of-the-art of 3D cultures (organs-on-achip) in safety testing and pathophysiology. ALTEX 31(4):441–477
16. Lai Y, Asthana A, Cheng K, Kisaalita WS (2011) Neural cell 3D microtissue formation is marked by cytokines’ up-regulation. PLoS One 6(10):e26821
17. Tilson HA (1992) Study design considerations in developmental neurotoxicology. Neurotoxicol Teratol 14(3):199–203
18. Mileson BE, Ferenc SA (2001) Methods to identify and characterize developmental neurotoxicity for human health risk assessment: overview. Environ Health Perspect 109(Suppl 1):77–78
19. Hass U (2003) Current status of developmental neurotoxicity: regulatory view. Toxicol Lett 140:155–159
20. Kaufmann W (2003) Current status of developmental neurotoxicity: an industry perspective. Toxicol Lett 140:161–169
21. Hanke T (2006) Lessons from TGN1412. Lancet 368(9547):1569–1570
22. Leist M, Hartung T (2013) Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol 87(4):563–567
23. Bal-Price A, Crofton, Kevin M., Shafer, Timothy, Sachana, Magdalini, Behl, Mamta, Forsby, Anna, Hargreaves, Alan, Landesmann, Brigitte, Lein, Pamela J., Louisse, Jochem, Monnet-Tschudi, Florianne, Paini, Alicia, Rolaki, Alexandra, Schrattenholz, André, Suñol, Cristina, van Thriel, Christoph, Whelan, Maurice, Fritsche, Ellen (2014) Workshop report: Adverse Outcome Pathways (AOP) relevant to neurotoxicity. (in press)
24. Crofton K, Fritsche E, Ylikomi T, Bal-Price A (2014) International STakeholder NETwork (ISTNET) for Creating a Developmental Neurotoxicity Testing (DNT) roadmap for regulatory purposes. ALTEX 31 (2):223–224
25. Crofton KM, Mundy WR, Shafer TJ (2012) Developmental neurotoxicity testing: a path forward. Congenit Anom (Kyoto) 52 (3):140–146
26. EFSA (2013) Scientific opinion on the identification of pesticides to be included in cumulative assessment groups on the basis of their toxicological profile. EFSA J 11(7)
27. De Groot DM, Hartgring S, Van de Horst L, Moerkens M, Otto M, Bos-Kuijpers MH, Kaufmann WS, Lammers JH, O’Callaghan JP, Waalkens-Berendsen ID (2005) 2D and 3D assessment of neuropathology in rat brain after prenatal exposure to methylazoxymethanol, a model for developmental neurotoxicity. Reprod Toxicol 20(3):417–432
28. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA (2006) A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 60(3):253–264
29. Baumann J, Barenys M, Gassmann K, Fritsche E (2014) Comparative human and rat “neurosphere assay” for developmental neurotoxicity testing. Curr Protoc Toxicol 59:12.21.1–12.21.24
30. Reynolds BA, Tetzlaff W, Weiss S (1992) A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12(11):4565–4574
31. Reynolds BA, Weiss S (1996) Clonal and population analyses demonstrate that an EGFresponsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175(1):1–13
32. Svendsen C, Fawcett J, Bentlage C, Dunnett S (1995) Increased survival of rat EGFgenerated CNS precursor cells using B27 supplemented medium. Exp Brain Res 102 (3):407–414
33. Gritti A, Parati E, Cova L, Frolichsthal P, Galli R, Wanke E, Faravelli L, Morassutti D, Roisen F, Nickel D (1996) Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 16(3):1091–1100
34. Kornblum HI, Hussain R, Wiesen J, Miettinen P, Zurcher SD, Chow K, Derynck R, Werb Z (1998) Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J Neurosci Res 53(6):697–717
35. Moors M, Rockel TD, Abel J, Cline JE, Gassmann K, Schreiber T, Schuwald J, Weinmann N, Fritsche E (2009) Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 117(7):1131–1138
36. Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368(9553):2167–2178
37. Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity. Lancet Neurol 13(3):330–338
38. Bose R, Onishchenko N, Edoff K, Lang AMJ, Ceccatelli S (2012) Inherited effects of lowdose exposure to methylmercury in neural stem cells. Toxicol Sci 130:383–390
39. Burke K, Cheng Y, Li B, Petrov A, Joshi P, Berman RF, Reuhl KR, DiCicco-Bloom E (2006) Methylmercury elicits rapid inhibition of cell proliferation in the developing brain and decreases cell cycle regulator, cyclin E. Neurotoxicology 27(6):970–981
40. Amorim MI, Mergler D, Bahia MO, Dubeau H, Miranda D, Lebel J, Burbano RR, Lucotte M (2000) Cytogenetic damage related to low levels of methyl mercury contamination in the Brazilian Amazon. An Acad Bras Cienc 72 (4):497–507
41. Buzanska L, Sypecka J, Nerini‐Molteni S, Compagnoni A, Hogberg HT, del Torchio R, Domanska‐Janik K, Zimmer J, Coecke S (2009) A human stem cell‐based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells 27(10):2591–2601
42. Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28(1):1–10
43. Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64(16):2090–2103
44. Go HS, Kim KC, Choi CS, Jeon SJ, Kwon KJ, Han SH, Lee J, Cheong JH, Ryu JH, Kim CH, Ko KH, Shin CY (2012) Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK3beta/beta-catenin pathway. Neuropharmacology 63(6):1028–1041
45. Foti SB, Chou A, Moll AD, Roskams AJ (2013) HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain. Int J Dev Neurosci 31(6):434–447
46. Barkovich A, Kuzniecky R, Jackson G, Guerrini R, Dobyns W (2005) A developmental and genetic classification for malformations of cortical development. Neurology 65 (12):1873–1887
47. Yang Y, Fung SJ, Rothwell A, Tianmei S, Weickert CS (2011) Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 69(1):63–70
48. Volk DW, Matsubara T, Li S, Sengupta EJ, Georgiev D, Minabe Y, Sampson A, Hashimoto T, Lewis DA (2012) Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatr 169 (10):1082–1091
49. Bozzi Y, Casarosa S, Caleo M (2012) Epilepsy as a neurodevelopmental disorder. Front Psychiatr 3:19
50. Moors M, Cline JE, Abel J, Fritsche E (2007) ERK-dependent and-independent pathways trigger human neural progenitor cell migration. Toxicol Appl Pharmacol 221(1):57–67
51. Parsons SJ, Parsons JT (2004) Src family kinases, key regulators of signal transduction. Oncogene 23(48):7906–7909
52. Frank CL, Tsai L-H (2009) Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity. Neuron 62(3):312–326
53. Tegenge MA, Rockel TD, Fritsche E, Bicker G (2011) Nitric oxide stimulates human neural progenitor cell migration via cGMPmediated signal transduction. Cell Mol Life Sci 68(12):2089–2099
54. Fahrion JK, Komuro Y, Li Y, Ohno N, Littner Y, Raoult E, Galas L, Vaudry D, Komuro H (2012) Rescue of neuronal migration deficits in a mouse model of fetal Minamata disease by increasing neuronal Ca2+ spike frequency. Proc Natl Acad Sci 109(13):5057–5062
55. Matsomoto H, Koya G, Takeuchi T (1965) Fetal Minamata disease: a neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol 24(4):563–574
56. Amin-Zaki L, Majeed MA, Elhassani SB, Clarkson TW, Greenwood MR, Doherty RA (1979) Prenatal methylmercury poisoning: clinical observations over five years. Am J Dis Child 133(2):172–177
57. Eto K (1997) Review article: pathology of Minamata disease. Toxicol Pathol 25 (6):614–623
58. Schettler T (2001) Toxic threats to neurologic development of children. Environ Health Perspect 109(Suppl 6):813–816
59. Clarkson TW (2002) The three modern faces of mercury. Environ Health Perspect 110 (Suppl 1):11–23
60. Kakita A, Inenaga C, Sakamoto M, Takahashi H (2002) Neuronal migration disturbance and consequent cytoarchitecture in the cerebral cortex following transplacental administration of methylmercury. Acta Neuropathol 104(4):409–417
61. Mancini JD, Autio DM, Atchison WD (2009) Continuous exposure to low concentrations of methylmercury impairs cerebellar granule cell migration in organotypic slice culture. Neurotoxicology 30(2):203–208
62. Rice D, Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(Suppl 3):511–533
63. Ayuso-Sacido A, Moliterno JA, Kratovac S, Kapoor GS, O’Rourke DM, Holland EC, Garcia-Verdugo JM, Roy NS, Boockvar JA (2010) Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J Neuro-Oncol 97 (3):323–337
64. Masuo Y, Ishido M (2011) Neurotoxicity of endocrine disruptors: possible involvement in brain development and neurodegeneration. J Toxicol Environ Health B Crit Rev 14(5 7):346–369
65. Kim K, Son TG, Park HR, Kim SJ, Kim HS, Kim HS, Kim TS, Jung KK, Han SY, Lee J (2009) Potencies of bisphenol A on the neuronal differentiation and hippocampal neurogenesis. J Toxic Environ Health A 72(2122):1343–1351
66. Guerri C, Ma P, Renau-Piqueras J (2001) Glia and fetal alcohol syndrome. Neurotoxicology 22(5):593–599
67. Hatten ME (1999) Central nervous system neuronal migration. Annu Rev Neurosci 22 (1):511–539
68. Ortega JA, Alcantara S (2010) BDNF/ MAPK/ERK-induced BMP7 expression in the developing cerebral cortex induces premature radial glia differentiation and impairs neuronal migration. Cereb Cortex 20 (9):2132–2144
69. Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ (2013) Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 106–107:1–16
70. Workman AD, Charvet CJ, Clancy B, Darlington RB, Finlay BL (2013) Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci 33(17):7368–7383
71. Burry M, Guizzetti M, Oberdoerster J, Costa LG (2003) Developmental neurotoxicity of toluene: in vivo and in vitro effects on astroglial cells. Dev Neurosci 25(1):14–19
72. Valles S, Sancho‐Tello M, Minana R, Climent E, Renau‐Piqueras J, Guerri C (1996) Glial fibrillary acidic protein expression in rat brain and in radial glia culture is delayed by prenatal ethanol exposure. J Neurochem 67 (6):2425–2433
73. Vemuri MC, Chetty CS (2005) Alcohol impairs astrogliogenesis by stem cells in rodent neurospheres. Neurochem Int 47(12):129–135
74. Clarren SK, Alvord EC Jr, Sumi SM, Streissguth AP, Smith DW (1978) Brain malformations related to prenatal exposure to ethanol. J Pediatr 92(1):64–67
75. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81 (2):871–927
76. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17 (4):595–606
77. Mabie P, Mehler M, Marmur R, Papavasiliou A, Song Q, Kessler J (1997) Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial–astroglial progenitor cells. J Neurosci 17(11):4112–4120
78. Bond AM, Bhalala OG, Kessler JA (2012) The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation. Dev Neurobiol 72(7):1068–1084
79. Barateiro A, Fernandes A (2014) Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. Biochim Biophys Acta 1843 (9):1917–1929
80. Ibarrola N, Rodríguez-Peña A (1997) Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development. Brain Res 752(1):285–293
81. Marta CB, Adamo AM, Soto EF, Pasquini JM (1998) Sustained neonatal hyperthyroidism in the rat affects myelination in the central nervous system. J Neurosci Res 53 (2):251–259
82. Rodriguez-Pena A, Ibarrola N, Iñiguez MA, Munoz A, Bernal J (1993) Neonatal hypothyroidism affects the timely expression of myelin-associated glycoprotein in the rat brain. J Clin Investig 91(3):812–818
83. Eschenroeder AC, Vestal‐Laborde AA, Sanchez ES, Robinson SE, Sato‐Bigbee C (2012) Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ‐opioid‐and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy. Glia 60(1):125–136
84. Sanchez ES, Bigbee JW, Fobbs W, Robinson SE, Sato‐Bigbee C (2008) Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia 56(9):1017–1027
85. Todorich B, Olopade JO, Surguladze N, Zhang X, Neely E, Connor JR (2011) The mechanism of vanadium-mediated developmental hypomyelination is related to destruction of oligodendrocyte progenitors through a relationship with ferritin and iron. Neurotox Res 19(3):361–373
86. He L-f, H-j C, L-h Q, G-y C, Buzby JS (2010) Curcumin protects preoligodendrocytes from activated microglia in vitro and in vivo. Brain Res 1339:60–69
87. Deng W, Poretz RD (2003) Oligodendroglia in developmental neurotoxicity. Neurotoxicology 24(2):161–178
88. Eskes C, Honegger P, Jones-Lepp T, Varner K, Matthieu J-M, Monnet-Tschudi F (1999) Neurotoxicity of dibutyltin in aggregating brain cell cultures. Toxicol In Vitro 13 (4):555–560
89. Honegger P, Richelson E (1976) Biochemical differentiation of mechanically dissociated mammalian brain in aggregating cell culture. Brain Res 109(2):335–354
90. Monnet-Tschudi F, Zurich M-G, Honegger P (1996) Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res 741(1):52–59
91. Strachan T, Read AP (1999) Genetic manipulation of animals (Chapter 21). In: Human molecular genetics, 2nd edn. New York: Wiley-Liss
92. Bockamp E, Maringer M, Spangenberg C, Fees S, Fraser S, Eshkind L, Oesch F, Zabel B (2002) Of mice and models: improved animal models for biomedical research. Physiol Genomics 11(3):115–132
93. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci 110(9):3507–3512
94. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O’Collins V, Macleod MR (2010) Can animal models of disease reliably inform human studies? PLoS Med 7 (3):e1000245
95. Colosimo A, Goncz K, Holmes A, Kunzelmann K, Novelli G, Malone R, Bennett M, Gruenert D (2000) Transfer and expression of foreign genes in mammalian cells. Biotechniques 29(2):314–331
96. Dean DA, Gasiorowski JZ (2011) Liposomemediated transfection. Cold Spring Harb Protoc 2011(3):prot5583
97. Jacobsen F, Mertens-Rill J, Beller J, Hirsch T, Daigeler A, Langer S, Lehnhardt M, Steinau H-U, Steinstraesser L (2006) Nucleofection: a new method for cutaneous gene transfer? BioMed Res Int 2006(5):26060
98. Maasho K, Marusina A, Reynolds NM, Coligan JE, Borrego F (2004) Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system™. J Immunol Methods 284(1):133–140
99. Coura R (2012) Viral vectors in neurobiology: therapeutic and research applications. Molecular virology, Chapter 5. pp 75–92
100. Tiscornia G, Singer O, Verma IM (2006) Production and purification of lentiviral vectors. Nat Protoc 1(1):241–245
101. Slack RS, Miller FD (1996) Viral vectors for modulating gene expression in neurons. Curr Opin Neurobiol 6(5):576–583
102. Yuan H, Zhai P, Anderson LM, Pan J, Thimmapaya B, Koo EH, Marquez-Sterling NR (1999) Recombinant adenovirus is an appropriate vector for endocytotic protein trafficking studies in cultured neurons. J Neurosci Methods 88(1):45–54
103. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T (2001) A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414 (6860):212–216
104. L’Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Impagnatiello F, Pluchino S, Marchetti B (2013) Aging-induced Nrf2ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation. J Neurosci 33(4):1462–1485
105. Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY-F, Cai Z, Pang Y, Rodriguez-Porcel F, Paul IA, Merzenich M, Lin RC (2011) Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci 108(45):18465–18470
106. Esch MB, Smith AS, Prot J-M, Oleaga C, Hickman JJ, Shuler ML (2014) How multi-organ microdevices can help foster drug development. Adv Drug Deliv Rev 69:158–169
107. Lee JB, Sung JH (2013) Organ‐on‐a‐chip technology and microfluidic whole‐body models for pharmacokinetic drug toxicity screening. Biotechnol J 8 (11):1258–1266
108. Schimek K, Busek M, Brincker S, Groth B, Hoffmann S, Lauster R, Lindner G, Lorenz A, Menzel U, Sonntag F (2013) Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip 13 (18):3588–3598
109. Hewett JA (2009) Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system. J Neurochem 110(6):1717–1736
110. Costa LG, Fattori V, Giordano G, Vitalone A (2007) An in vitro approach to assess the toxicity of certain food contaminants: methylmercury and polychlorinated biphenyls. Toxicology 237(1):65–76
111. Bal-Price A, Crofton KM, Leist M, Allen S, Arand M, Buetler T, Delrue N, FitzGerald R, Hartung T, Heinonen T, Hogberg H, Hougaard S, Lichtensteiger W, Oggier D, Paparella M, Petersen MA, Piersma A, Rached E, Schilter B, Schmuck G, Stoppini L, Tongiorgi E, Tiramani M, Tschudi-Monnet F, Wilks M, Ylikomi T, Fritsche E (2014) International STakeholder NETwork (ISTNET) for creating a Developmental Neurotoxicity Testing (DNT) roadmap for regulatory purposes. Arch Toxicol Rep. In press
112. Baumann J, Gassmann K, Masjosthusmann S, DeBoer D, Bendt F, Giersiefer S, Fritsche E (2015) Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events. Arch Toxicol. In Press